모아라이프플러스

142760KOSDAQSector: Pharma & Biotech

₩375▼ 2.60%Market cap ₩15.8BAs of Jul 21, 2026 close · updated once daily

Grade D40.4 ptsTop 70% of 2,523 stocks

Financial strength

43.2

Growth momentum

28.6

Price attractiveness

45.6

As of Jul 21, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

Financial strength

43.2

How much debt does it carry relative to equity?

Debt-to-equity ratio

39.4%

✓ Above median · Top 37.2% in sector

Sector median 51.5%

Can it cover what's due within a year?

Current ratio

231.4%

✓ Above median · Top 40.4% in sector

Sector median 191.3%

How much of revenue becomes profit?

Operating margin

-58.2%

✗ Below median · Top 68.9% in sector

Sector median -2.3%

How much did it earn on its own capital?

ROE (return on equity)

-42.7%

✗ Below median · Top 80.7% in sector

Sector median -4.5%

Source filing: annual report (consolidated) — view original ↗

Growth momentum

28.6

How much did revenue grow in a year?

Revenue growth (YoY)

-28.2%

✗ Below median · Top 91.6% in sector

Sector median 6.4%

Has it grown steadily over three years?

Revenue 3-year CAGR

-51.8%

✗ Below median · Top 96.4% in sector

Sector median 4.9%

Did core profits grow in a year?

Operating income change (YoY)

-17.9%

✗ Below median · Top 69.9% in sector

Sector median 3.6%

Are core profits higher than three years ago?

Operating income change (3Y)

55.3%

✓ Above median · Top 27.7% in sector

Sector median 3.5%

Source filing: annual report (consolidated) — view original ↗

Price attractiveness

45.6

Is the price expensive relative to earnings?

P/E (price-to-earnings)

Loss-making (P/E not computable)

✗ Below median · Top 95.7% in sector

Sector median P/E of profitable peers 14.4x · 57% loss-making

Is the price expensive relative to book value?

P/B (price-to-book)

0.52x

✓ Above median · Top 13.2% in sector

Sector median 1.39x

Valuation uses the Jul 21, 2026 close and market cap

Grade distribution of 248 stocks in Pharma & Biotech

S1A52B66C51D61F15